General Information of DTT (ID: TTC8M31)

DTT Name Carnitine acyltransferase (CRAT) DTT Info
UniProt ID
CACP_HUMAN
Gene Name CRAT

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Investigative Drug(s)
Discontinued Drug(s)
2 Discontinued Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Teglicar DMPCRUT Diabetic complication 5A2Y Discontinued in Phase 2 [1]
LXR-015-2 DMXYDJR Ischemia 8B10-8B11 Terminated [2]
------------------------------------------------------------------------------------
1 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Coenzyme A DM1I8LU Discovery agent N.A. Investigative [3]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Selective Reversible Inhibition of Liver Carnitine Palmitoyl-Transferase 1 by Teglicar Reduces Gluconeogenesis and Improves Glucose Homeostasis. Diabetes. 2011 February; 60(2): 644-651.
2 EDG receptors as a potential therapeutic target in retinal ischemia-reperfusion injury. Brain Res. 2006 Nov 6;1118(1):168-75.
3 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.